Massimo Breda, Director of P&PD-Bioanalytical Sciences.
Massimo Breda is Director of Bioanalytical Sciences Department in Pharmaceutical & Preclinical Development Business unit at Aptuit, Verona, Italy. He has a wide experience of development and validation of bioanalytical methods for the determination of drugs in biological matrices to support preclinical and clinical studies according to international guidelines and following GLP and GCP regulations. He has also good experience in dose formulation analysis to support preclinical studies. Prior to joining Aptuit in December 2013, Massimo was Head of Bioanalysis Department in Accelera S.r.l, Nerviano, Milan, Italy, managing bioanalytical activities for small and large molecules. He spent about 25 years in the bioanalytical department in Nerviano Campus (also formerly known as Farmitalia Carlo, Pharmacia, Pharmacia & Upjohn, Pharmacia Italia and Pfizer). Massimo has a degree in Chemistry and Pharmaceutical Technology from the University of Pavia in Italy and he is member of Ordine dei Farmacisti. He has been council member of Analytical Chemistry division of Italian Chemistry Society and he organized several bioanalytical meetings. Massimo is author and co-author of more than one hundred publications in international journals and communication to international congresses.